Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy

Authors

Lai Man Natalie Wu, Cincinnati Children's Hospital Medical Center
Joshua Rubin, Washington University School of Medicine in St. Louis
et al.

Journal

Science Advances

Publication Date

11-4-2022

Volume

8

Issue

44

First Page

eabo5442

Document Type

Open Access Publication

DOI

10.1126/sciadv.abo5442

Rights and Permissions

Wu LMN, Zhang F, Rao R, Adam M, Pollard K, Szabo S, Liu X, Belcher KA, Luo Z, Ogurek S, Reilly C, Zhou X, Zhang L, Rubin J, Chang LS, Xin M, Yu J, Suva M, Pratilas CA, Potter S, Lu QR. Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. Sci Adv. 2022 Nov 4;8(44):eabo5442. doi: 10.1126/sciadv.abo5442 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

Recommended Citation

Wu, Lai Man Natalie; Rubin, Joshua; and et al., "Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy." Science Advances. 8, 44. eabo5442 (2022).
https://digitalcommons.wustl.edu/oa_4/953

Additional Links

Supplemental material is available for this article at publisher site.